Status:

ENROLLING_BY_INVITATION

Validation Digital Bio-markers During Sulforaphane Treatment.

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Autism

Autism Spectrum Disorder

Eligibility:

MALE

13-30 years

Phase:

NA

Brief Summary

The purpose of the research is to determine if changes seen during sulforaphane treatment (a compound that comes from eating certain vegetables) can better be understood using digital biomarkers. Thes...

Detailed Description

This study is a pilot open label treatment trial with SF (sulforaphane) in 10 individuals that have completed with moderate to severe autism, age 13-30 years that have completed participation in Clini...

Eligibility Criteria

Inclusion

  • Autistic disorder diagnosis.
  • Age between 13-30 years.
  • Male gender.
  • Participated in clinical trial NCT02677051

Exclusion

  • Those that started or continued taking Avmacol® or similar broccoli extracts since leaving our double-blind study.
  • Absence of a parent or legal guardian and consent,
  • Those that can not or will not complete all visits and adherence to study regimen.
  • Seizure within 2 years of screening,
  • History of chronic kidney, liver or thyroid disease.
  • Impaired renal function (serum creatinine\> 1.2 mg/dl).
  • Impaired hepatic function (\> 2x upper limit of normal).
  • Impaired thyroid function (TSH outside normal limits).
  • Current infection or treatment with antibiotics.
  • Chronic medical disorder (e.g., cardiovascular disease, stroke or diabetes) or major surgery within 3 months prior to enrollment.
  • Less than 13 years or more than 30 years of age.
  • Female gender.
  • A diagnosis of autism spectrum disorder other than autistic disorder, for example, Asperger, PDD-NOS ( Pervasive Developmental Disorder-Not Otherwise Specified) etc.

Key Trial Info

Start Date :

July 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04805957

Start Date

July 7 2022

End Date

June 1 2027

Last Update

October 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers-RWJMS Department of Neurology

Piscataway, New Jersey, United States, 08854